Tumor specificity was demonstrated by competition studies using excess of the CCK-2R-specific compound, [natLu]Lu-DOTA-MGS5 [28], which led to tumor and stomach values <2 %ID/g. The gene discussed is CCKBR; the disease is neoplasm.